Table 2 Available clinical trials of the application of MSCs in AKI
ClinicalTrials.gov identifier | Year | Aim | MSC type | Enrollment | Phase | Status | Outcomes |
|---|---|---|---|---|---|---|---|
NCT00733876 | 2008 | For the prevention of developing AKI after cardiac surgery | Allogeneic | 16 | Phase I | Completed | Safe and effective |
NCT01602328 | 2017 | For the treatment of AKI after cardiac surgery | Allogeneic | 156 | Phase II | Terminated | Safe but not effective |
NCT01275612 | 2018 | For the treatment of cisplatin-induced AKI in cancer patients | Allogeneic | NM | Phase I | Withdrawn | NM |
NCT03015623 | 2018 | For the treatment of AKI regardless of the underlying reasons | Allogeneic MSCs combined with a biologic device | 24 | Phase I | Recruiting | Date not published |